ShockWave Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ShockWave Medical generated cash of $196,053,000, which is more than the previous year. Cash used in financing activities reached the amount of $600,401,000 last year. Net change in cash is therefore $171,836,000.
Cash Flow
| 2017 | -30.34M | -2.23M | 33.68M |
|---|---|---|---|
| 2018 | -41.46M | -174K | 29.80M |
| 2019 | -48.10M | -59.54M | 208.05M |
| 2020 | -71.18M | -107.47M | 90.03M |
| 2021 | 15.03M | 26.41M | -2.45M |
| 2022 | 117.73M | -62.15M | 12.99M |
| 2023 | 196.05M | -625.72M | 600.40M |
SWAV Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 156.58M | 90.87M | 51.87M | 140.49M | 40.09M | 51.92M | 50.81M |
Operating activities | |||||||
Net income | 147.27M | 215.99M | -9.13M | -65.69M | -51.10M | -41.10M | -30.61M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 10.35M | 4.85M | 5.53M | 3.34M | 2.28M | 700K | 468K |
Stock-based compensation expense | 73.23M | 44.89M | 27.25M | 10.35M | 3.64M | 0 | 965K |
| Deferred income tax benefit | 73.23M | 44.89M | 27.25M | 10.35M | 3.64M | 0 | 965K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -41.53M | -33.31M | -25.74M | -4.31M | -4.52M | -2.21M | -594K |
Inventories | -31.00M | -29.71M | -12.07M | -17.05M | -6.82M | -2.60M | -1.86M |
Accounts payable | 112K | 1.94M | 1.87M | -1.39M | 1.27M | 360K | 249K |
Cash generated by operating activities | 196.05M | 117.73M | 15.03M | -71.18M | -48.10M | -41.46M | -30.34M |
Investing activities | |||||||
Purchases Of Investments | -747.47M | -137.79M | -117.24M | -167.95M | -119.47M | 0 | -17.70M |
Investments In Property Plant And Equipment | -30.59M | -25.12M | -12.43M | -11.52M | -3.81M | -1.98M | -425K |
Acquisitions Net | -94.41M | 37.02M | -26.41M | 95.95M | 55.72M | 0 | 0 |
Cash generated by investing activities | -625.72M | -62.15M | 26.41M | -107.47M | -59.54M | -174K | -2.23M |
Financing activities | |||||||
Common Stock Issued | 7.60M | 7.04M | 5.88M | 89.48M | 207.40M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -43K | -23K | -8.33M | -1.42M | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.15M | 0 | 0 | 0 |
Cash used in financing activities | 600.40M | 12.99M | -2.45M | 90.03M | 208.05M | 29.80M | 33.68M |
Net Change In Cash | 171.83M | 67.42M | 39.00M | -88.62M | 100.40M | -11.83M | 1.10M |
Cash at end of period | 328.42M | 158.30M | 90.87M | 51.87M | 140.49M | 40.09M | 51.92M |
| Data source | Data source | Data source | Data source | Data source |